期刊文献+

TRAIL联合顺铂对小鼠移植型肝癌抑制作用及机制研究 被引量:1

Inhibitory action and mechanism of trail combined with cisplatin on transplanted hepatocellular carcinoma in mice
下载PDF
导出
摘要 目的探讨肿瘤坏死因子相关的凋亡诱导配体(tumor necrosis factor-related apoptosis inducing ligand,TRAIL)联合顺铂(cisplatin,DDP)对小鼠移植型肝癌的抑制作用及机制。方法将H22小鼠移植型肝癌模型随机分为生理盐水组、TRAIL组、TRAIL+DDP组和DDP组,称取瘤重并分析抑瘤率,Hoechst 33342荧光染色法检测细胞凋亡,免疫组织化学染色检测Caspase-3表达。结果与生理盐水组比较,TRAIL、DDP对小鼠移植型肝癌生长具有明显的抑制作用(P<0.05);TRAIL与DDP联合用药具有增效作用(P<0.05),可明显提高肝癌细胞的凋亡率(P<0.05)、上调Caspase-3表达(P<0.01)。结论 TRAIL与DDP联合用药对小鼠移植型肝癌生长具有协同抑制作用,其机制可能与其协同促进Caspase-3的表达有关。 Objective To study the mechanism and the inhibitory action of TRAIL combined with DDP on transplanted hepatocellular carcinoma in mice. Methods Mice bearing H22 hepatocellular carcinoma were randomly divided into normal saline(NS) group,TRAIL group,TRAIL+DDP group,and DDP group.Tumor tissues were weighted and the inhibitory rate was analysed.Hoechst 33342 stainning method was used to calculate the apoptotic cells.The expression of Caspase-3 was measured by immunohistochemistry. Results Compared with NS,both TRAIL and DDP obviously inhibited the growth of transplanted hepatocellular carcinoma in mice(P0.05).They had a synergistic effect(P0.05) and obviously increased the apoptotic rate of cancer cells(P0.05)and the expression of Caspase-3(P0.01). Conclusion The combination of TRAIL with DDP has a synergisticly inhibitory effect on the growth of transplanted hepatocellular carcinoma in mice,and the mechanism may be associated with the synergistic upregulation of Caspase-3 expression.
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2012年第2期130-133,共4页 Chinese Journal of Histochemistry and Cytochemistry
基金 山东省优秀中青年科学家科研奖励基金(01BS51) 山东省自然科学基金(Y2008C95) 滨州医学院科技计划(BY2008KJ27)
关键词 肝癌 肿瘤坏死因子相关的凋亡诱导配体 顺铂 CASPASE-3 Hepatocellular carcinoma TRAIL DDP Caspase-3
  • 相关文献

参考文献11

  • 1Griffith TS,Anderson RD,Davidson BL. Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis[J].Journal of Immunology,2000,(05):2886-2894.
  • 2Almasan A,Ashkenazi A. Apo2L/TRAIL:Apoptosis signaling,biology and potential for cancer therapy[J].Cytokine & Growth Factor Reviews,2003,(3-4):337-348.
  • 3Ding L,Yuan C,Wei F. Cisplatin restores TRAIL apoptotic pathway in glioblastoma-derived stem cells through up-regulation of DR5 and down-regulation of c-FLIP[J].Cancer Investigation,2011.
  • 4Baritaki S,Huerta-Yepez S,Sakai T. Chemotherapeutic drugs sensitize cancer cells to TRAIL-mediated apoptosis:up-regulation of DR5 and inhibition of Yin Yang 1[J].Molecular Cancer Therapeutics,2007,(04):1387-1399.
  • 5Yin S,Xu L,Bandyopadhyay S. Cisplatin and TRAIL enhance breast cancer stem cell death[J].International Journal of Oncology,2011,(04):891-898.
  • 6Xu L,Yin S,Banerjee S. Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cella[J].Molecular Cancer Therapeutics,2011,(03):550-557.
  • 7Shin EC,Seong YR,Kim CH. Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis,and the reisitance is abolished by cisplatin[J].Experimental and Molecular Medicine,2002,(02):114-122.
  • 8周慧明,陈智,陈公英,李敏伟.TRAIL联合化疗药物诱导肝癌细胞凋亡的实验研究[J].中华肿瘤杂志,2003,25(2):152-153. 被引量:13
  • 9胥瑜,闫娟,李旭锋,陈守春.TRAIL联合顺铂和IFN-α对人肝癌细胞凋亡的影响[J].华西药学杂志,2007,22(4):390-392. 被引量:4
  • 10Siervo-Sassi RR,Marrangoni,Feng X. Physiological and molecular effects of Apo2L/TRAIL and cisplafin in ovarian carcinoma cell lines[J].Cancer Letters,2003,(10):61-72.

二级参考文献8

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of new member of the TNF family. Immunity, 1995, 3:673-682.
  • 2Mini JO, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand.Nat Med, 2000,6: 564-567.
  • 3Weihong Liu, Ethan Bodlc, Jcssica Y Chen, et al. Tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy cooperate to induce apoptosis in mesothelioma cell lines. Am J Respir Cell Molec Biol, 2001, 7: 111-120.
  • 4Nagane M,Pan G,Weddle JJ,et al.Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity wit h tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo[J].Cancer Res,2000,60(4):847-853.
  • 5Skehan P,Storeng R,Scudiero D,et al.New colorimetric cytotoxicity assay for anticaneer-drug screening[J].Natl Cancer Inst,1990,82(13):1107-1112.
  • 6Sprick MR,Weigand MA,Rieser E,et al.FADD/ MORT1 and caspase-8 are recruited to TRAIL receptors1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2[J].Immunity,2000,12 (6):599-609.
  • 7Kischkel FC,Lawrence DA,Chuntharapai A,et al.Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5[J].Immunity,2000,12(6):611-620.
  • 8Christian L,Nadine G,Michael PM.Interferon-α enhances TRAIL-mediated apoptosis by up-regulating caspase-8 transcription in human hepatoma cells[J].J Hepatol,2006,44(2):342-349.

共引文献15

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部